Anne Escande

880 total citations
5 papers, 44 citations indexed

About

Anne Escande is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anne Escande has authored 5 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Anne Escande's work include Pancreatic and Hepatic Oncology Research (2 papers), Bone health and treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Anne Escande is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Bone health and treatments (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Anne Escande collaborates with scholars based in France, Switzerland and Belgium. Anne Escande's co-authors include Vincent Bourgeois, Christophe Desauw, Capucine Baldini, Olivier Bouché, Mohamed Hebbar, Farid El Hajbi, Julien Volet, Yohann Loriot, Philippe Barthélémy and Éric Voog and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Pancreatology.

In The Last Decade

Anne Escande

5 papers receiving 44 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Escande France	3	32	23	23	11	6	5	44
Marcela Carballido Argentina	5	35 1.1×	38 1.7×	23 1.0×	11 1.0×	5 0.8×	11	68
Fabiana Sousa Portugal	4	27 0.8×	21 0.9×	35 1.5×	8 0.7×	7 1.2×	10	60
I. García-Carbonero Spain	5	45 1.4×	38 1.7×	29 1.3×	9 0.8×	7 1.2×	11	71
Chara Ntala United Kingdom	4	48 1.5×	22 1.0×	15 0.7×	16 1.5×	16 2.7×	8	67
Stephen McCain United Kingdom	4	17 0.5×	28 1.2×	18 0.8×	7 0.6×	5 0.8×	11	60
Telma Fonseca Portugal	3	31 1.0×	19 0.8×	28 1.2×	10 0.9×	5 0.8×	11	57
Sonia Mansukhani United Kingdom	4	25 0.8×	21 0.9×	28 1.2×	19 1.7×	18 3.0×	6	63
Gabriel D. Ivey United States	4	29 0.9×	37 1.6×	13 0.6×	4 0.4×	5 0.8×	6	69
Joel Berends United States	4	36 1.1×	17 0.7×	33 1.4×	7 0.6×	4 0.7×	7	68
Åsa Dahle-Smith United Kingdom	5	26 0.8×	29 1.3×	38 1.7×	6 0.5×	3 0.5×	8	47

Countries citing papers authored by Anne Escande

Since Specialization

Citations

This map shows the geographic impact of Anne Escande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Escande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Escande more than expected).

Fields of papers citing papers by Anne Escande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Escande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Escande. The network helps show where Anne Escande may publish in the future.

Co-authorship network of co-authors of Anne Escande

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Escande. A scholar is included among the top collaborators of Anne Escande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Escande. Anne Escande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Roubaud, Guilhem, Marie Kostine, Ray McDermott, et al.. (2025). Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial. European Journal of Cancer. 218. 115293–115293. 2 indexed citations

2.

Barthélémy, Philippe, Yohann Loriot, Éric Voog, et al.. (2023). Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).. Journal of Clinical Oncology. 41(6_suppl). 471–471. 12 indexed citations

3.

Roubaud, Guilhem, Marie Kostine, Ray McDermott, et al.. (2022). Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial.. Journal of Clinical Oncology. 40(6_suppl). 19–19. 4 indexed citations

4.

Baldini, Capucine, Anne Escande, Olivier Bouché, et al.. (2016). Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis. Pancreatology. 17(1). 146–149. 24 indexed citations

5.

Baldini, Capucine, Anne Escande, Olivier Bouché, et al.. (2015). 1326 Folfirinage: Tolerance and efficacy of folfirinox in elderly patients with advanced pancreatic adenocarcinoma. European Journal of Cancer. 51. S196–S196. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact